Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Volume Reduction and Process Optimization with Cadence Inline Concentrator

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma

Productivity and Economic Advantages of Coupling Single-Pass Tangential Flow Filtration to Multi-Column Chromatography for Continuous Processing

Mark Schofield, Ph.D., Karl Rogler, Xhorxhi Gjoka, Engin Ayturk, Ph.D., and René Gantier, Ph.D.

View All Featured Articles

Headline News

Zura Bio discontinues tibulizumab development in hidradenitis suppurativa after Phase II miss

Allergan Aesthetics reports improved facial satisfaction in GLP-1 users after aesthetic treatments

Onchilles reports early systemic activity with intratumoral N17350 in Phase I/II trial

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

The Paperless Laboratory: A Way Into Process Optimisation

Presented by Peter Boogaard
05th November 2015

The Journey to Lean Implementation for Efficiency Increase

Presented by Uwe Voelker, Site Head, Sterile Drug Product Manufacturing at Roche
04th September 2019

Effect of Cell Culture Process Change from Fed-batch to Continuous on Productivity and Product Quality

Presented by Ru Zang, Associate Director at Mersana Therapeutics and John Bonham Carter, Product Line Lead, Cell Culture and Clarification Business at Repligen
25th February 2019

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos